Asthma flare-ups spike in the weeks after school starts, when viral exposure, allergens, and missed maintenance treatment can ...

Internal documents show contractor readiness concerns, decision delays, and high non-affirmation rates, while providers ...

A new survey examines young adults’ use of primary care, Nebraska receives funding for rural training, and Trinity Health expands services in West Michigan.

Survivors of bacterial meningitis have modestly higher mortality than their peers over nearly six decades, and their siblings ...

Cancer diagnoses among people exposed to the World Trade Center disaster continue to be reported 25 years after 9/11, ...

JAK inhibitors are linked to reduced disease activity and improved patient-reported outcomes in patients with rheumatoid arthritis, regardless of diabetes, cardiometabolic burden, or age.

Abemaciclib and ribociclib now show adjuvant survival benefit; palbociclib didn't. Laura Spring, MD, on picking the right agent per patient.

Apitegromab is the first SMA therapy to directly target muscle loss and is approved as add-on treatment for patients aged 2 years and older receiving an SMN2-targeted therapy.

Amid the backlash against paternalism and efforts to rebuild trust, an important ethical principle got caught in the fallout: ...

The modified Medical Research Council questionnaire (mMRC) and COPD Assessment Test (CAT) are objective measures of symptoms in patients with COPD, said lead author Andrew J. Gangemi, MD, associate ...

The agency expresses concern that a rise in use of postexposure prophylaxis could indicate a lack of understanding of when to administer the therapy.

For patients with small-cell lung cancer, skipping preventive cranial radiotherapy in favor of MRI monitoring may improve outcomes.